A new screening tool identified roughly half of primary care patients with chronic obstructive pulmonary disorder who could benefit from available treatments, according to a nationwide study.
Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn’s disease, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
An experimental contraceptive drug candidate developed by Weill Cornell Medicine investigators temporarily stops sperm in their tracks and prevents pregnancies in preclinical models.
Strokes cause changes in gene activity in affected small blood vessels in the brain, changes that may be targetable with existing or future drugs to mitigate brain injury or improve stroke recovery, according to Weill Cornell Medicine scientists.
A gene linked to autism spectrum disorders plays a critical role in early brain development and may shape the formation of nerve connections in the brain.
Sphingolipids – prominent molecules produced by bacteria in the gut microbiome – appear to ameliorate a problematic fatty liver, according to new Cornell nutrition research.
Using a biomaterials-based organoid, a multi-institution team led by Matt DeLisa of Cornell Engineering was able to assess the strength of the immune response to a glycoengineered vaccine in days, instead of months.
Sloan Program in Health Administration students will be working with five executives-in-residence. Sloan Program Associate Director Julie Carmalt says the students will have a range of mentoring and networking opportunities while learning from prominent leaders in the health care field.